Since, MUC4 acts as an oncogene during the progression and metastasis of pancreatic cancer [28], we hypothesized that in the absence of HER2, HER3 may interact with MUC4 to promote pancreatic cancer cell proliferation. This evidence concerns the gene ERBB2 and familial pancreatic carcinoma.